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 Background: Hyperlactatemia is a common phenomenon following cardiac surgeries and is associated with prolonged ICU 
stay and higher morbidity and mortality rates, but such analyses have never focused on patients undergoing 
heart transplantation (HTX), in whom hyperlactatemia defined with the traditional threshold is observed in 
nearly every individual. The present study aimed to assess the prognostic value and clinical usefulness of post-
operative serum lactate level measurements for in-hospital mortality prediction following HTX.
 Material/Methods: Forty-six consecutive patients who underwent HTX in the Department of Cardiovascular Surgery and Transplantology 
between 2010 and 2015 were enrolled into a retrospective analysis. Serum lactate level measurements with-
in the first 48 h after HTX were obtained from arterial blood gas analyses, that were routinely conducted ev-
ery 6 h. Lactate clearance was determined for each patient individually throughout 3 different time frames: the 
first 24-h (Lac clear 0–24) and second 24-h period (Lac clear 24–48), and the first 48 h after surgery (Lac clear 
0–48).
 Results: The ICU admission serum lactate levels differed between the deceased and survivors (7.6 vs. 4.3 mmol/L; 
p=0.000). Among all tested postoperative lactate level measurements, only the measurement taken upon ICU 
admission predicted in-hospital mortality (OR 1.94 95% CI [1.09–3.43]; p=0.024). The receiving operating char-
acteristic (ROC) curve for in-hospital mortality was constructed for ICU admission measurement, with the op-
timal cut-off point estimated at 7.0 mmol/L.
 Conclusions: Serum lactate level measurement upon ICU admission can be used as a predictive parameter for in-hospital 
mortality among heart transplant recipients. Values greater than 7.0 mmol/L can predict in-hospital mortality 
with 90% accuracy.
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Background
Hyperlactatemia is a common phenomenon following cardiac 
surgeries. Although it is frequently used as a marker of observed 
tissue hypoxia, lactate metabolism during the perioperative pe-
riod is complex and dynamic. Early-onset hyperlactatemia is 
defined as developing in the operating room or very early fol-
lowing Intensive Care Unit (ICU) admission and it usually does 
not spontaneously resolve within 24 h after surgery. De novo 
hyperlactatemia, which is not present up to 6 h following ICU 
admission, is accompanied by normal cardiac output and ab-
sence of impaired tissue oxygen delivery and is observed in 
approximately 15–20% of cardiosurgical patients [1]. Previous 
studies, comparing survivors vs. non-survivors following non-
transplant cardiac surgeries, have indicated that higher lactate 
levels upon ICU admission (2–3 mmol/l), or within early post-
operative hours (3–4 mmol/l), are associated with increased 
perioperative risk and prolonged hospital stay [2–5].
Nevertheless, such analysis, which would define the thresh-
old for increased postoperative risk of major complications, 
has never been performed in patients undergoing heart trans-
plantation (HTX). Among these individuals, higher postoper-
ative levels are expected, as end-organ hypoperfusion, need 
for inotropic and vasopressor support, and low cardiac output 
syndrome are commonly observed, and results from studies of 
other cardiac surgeries may not be comparable.
Therefore, this study aimed to assess the prognostic value and 
clinical usefulness of postoperative serum lactate level mea-
surements for in-hospital mortality prediction following HTX.
Material and Methods
Forty-six consecutive patients who underwent HTX in the 
Department of Cardiovascular Surgery and Transplantology 
between 2010 and 2015 were enrolled into this retrospec-
tive analysis. All patients who underwent HTX within the an-
alyzed period were included into the analysis. The majority 
of the study group were males (89.1%), with a mean age of 
48.7±11.7 years, and were qualified for HTX due to dilated 
cardiomyopathy (73.9%) (Table 1). Serum lactate level mea-
surements within the first 48 h after HTX were obtained from 
arterial blood gas analyses routinely assessed every 6 h. The ob-
servation made upon ICU admission was defined as the zero 
serum lactate measurement (Lac 0). Lactate clearance was cal-
culated based on the equation: ([lactateinitial–lactatedelayed]/lac-
tateinitial×100) [6], and was determined for each patient individ-
ually throughout 3 different time frames: the first 24-h period 
(Lacclear 0–24) and the second 24-h period (Lacclear 24–48), and 
the first 48 h after surgery (Lacclear 0–48). The threshold for 
hyperlactatemia was set at >1.6 mmol/L, based on internal 
laboratory standardization. The end-point was determined as 
death during hospitalization following HTX.
The study was approved by the Jagiellonian University Bioethics 
Committee (122.6120.74.2017). Verbal consent was obtained 
from all living patients. The study was funded by a grant from 
Jagiellonian University Medical College (K/ZDS/007226).
Statistical analysis
Statistical analysis was performed with IBM® SPSS® Statistics 
25. Normality of data distribution was tested using the Shapiro-
Wilk test. Continuous variables are presented as means and 
standard deviation (±SD) or medians and interquartile rang-
es (IQR). For categorical variables, numbers and proportions 
are reported. The non-parametric test for independent sam-
ples (Mann-Whitney U test) was used to assess differences be-
tween groups. Univariate regression analysis followed by multi-
variate regression were performed to explore the relationship 
between various serum lactate measurements and in-hospi-
tal mortality. All available serum lactate level measurements 
were included into the univariate analysis. Receiver operating 
characteristic (ROC) curves and respective areas under the ROC 
curves (AUC) were constructed to identify the optimal mark-
er and cut-off value.
Results
The ICU admission serum lactate level (Lac 0) differed between 
the deceased and survivors (7.6 vs. 4.3 mmol/L; p=0.000), with 
no differences observed in the lactate clearance parameters 
throughout the observation (Figure 1). In the multivariate re-
gression model, from all analyzed lactate parameters, only 





Male sex, n (%)  41 (89.1)
Dilated cardiomyopathy, n (%)  34 (73.9)
Ischemic cardiomyopathy, n (%)  12 (26.1)
Dyslipidemia, n (%)  16 (34.8)
Hypertension, n (%)  21 (45.7)
Diabetes, n (%)  12 (26.1)
Table 1. Baseline characteristics.
Data shown as mean±SD or as median (IQR), or number 
(percentage).
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predicted in-hospital mortality (OR 1.94 95% CI [1.09–3.43]; 
p=0.024) (Figure 2). The ROC for in-hospital mortality was con-
structed for the ICU admission serum lactate level (Lac 0), and 
the optimal cut-off value was estimated to be 7.0 mmol/L (67% 
sensitivity, 90% specificity) (Figure 3).
Discussion
Early-onset hyperlactatemia is strongly associated with post-
operative adverse events, presumably due to the complex 
pathogenesis, which combines hypoxic (circulatory or micro-
circulatory shock) and non-hypoxic (accelerated aerobic metab-
olism) mechanisms [1]. Because it reflects the status of tissue 
perfusion, it is used to predict early outcome in terms of mor-
tality, morbidity, and ICU length of stay following cardiosurgi-
cal procedures [2–5].
Nevertheless, adapting thresholds for serum lactate levels cor-
responding with higher postoperative risk, established for other 
cardiac surgeries, will not be clinically efficient, as serum lac-
tate levels observed early after HTX are higher, even among the 
survivors (Figure 1). However, to date, only 2 studies on post-
operative hyperlactatemia among heart transplant recipients 











































Median ICU admission serum lactate level (Lac o) by death
Survivors
In-hospital death
ICU admission serum lactate level distribution dier between groups: p=0.000; U Mann-Whitney test
Error bars: 95% CI
Data for serum lactate levels are presented as medians (IQR)
Lac 0 – upon ICU admission serum lactate measurement
Lacclear 0–24 – serum lactate clearance from rst 24 hours past-surgery
Lacclear 24–48 – serum lactate clearance from second 24 hours past-surgery
Lacclear 0–48 – serum lactate clearance from rst 48 hours past-surgery
Deceased
Figure 1.  ICU admission serum lactate level (Lac 0) by in-hospital death.
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Figure 2.  Selected postoperative lactate level measurements 
for in-hospital mortality prediction. A mutli-variate 
regression model.







AUC=0.783, SE 0.11; p=0.027
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Figure 3.  Receiver operating characteristic (ROC) curve for 
prediction of in-hospital mortality.
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by Hsu et al. as the serum lactate level over 15 mmol/L and 
was reported to have a prevalence rate of 20.7% in patients 
after HTX. Despite the further serum lactate level decrease 
below 4 mmol/L, all patients died either while in the hospi-
tal (33.3%) or within 5 years after HTX (66.6%) [7]. In another 
study, the cut-off level for postoperative hyperlactatemia was 
set according to the guidelines for severe sepsis and septic 
shock treatment (4 mmol/L). Based on this estimation, post-
operative hyperlactatemia was observed among two-thirds 
of the recipients, but no in-hospital deaths were reported [8]. 
Both of these studies only evaluated the fact of reaching the 
predefined threshold, which had never previously been de-
fined for heart transplant recipients. Based on the present 
study, which sought to define the threshold, the cut-off val-
ue of 7 mmol/L should be considered relevant for in-hospital 
mortality prediction (Figure 3).
Although single serum lactate concentration is potentially use-
ful, it does not contain directional information about the pa-
tient’s improvement or deterioration. Sequential serum lactate 
level measurements, which have been assessed for patients 
undergoing coronary artery bypass-grafting, mitral valve sur-
gery, or Norwood procedure, showed that high lactate con-
centration is associated with inability to clear blood lactate 
levels, and have highest predictive value for adverse out-
come [9–11]. However, among heart transplant recipients, no 
such association was found for lactate utilization ability and, 
unlike other cardiosurgical populations, hyperlactatemia was 
not combined with low lactate clearance values (Figure 1). 
Although metabolic pathways that provide lactate resolution 
are widely described in the literature [1], there is still limited 
knowledge regarding clinical features that might alter individ-
ual ability to clear serum lactate.
The greatest study limitation is the small sample size, which 
did not allow us to test the applicability of the estimated cut-
off value. However, we believe that setting a threshold to be 
tested and further investigated by other researchers will al-
low such data to be produced in the future.
Conclusions
Serum lactate level measurement upon ICU admission can be 
used as a predictive parameter for in-hospital mortality among 
heart transplant recipients. Values greater than 7.0 mmol/L can 
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